Followers | 3183 |
Posts | 208744 |
Boards Moderated | 2 |
Alias Born | 02/04/2004 |
Tuesday, May 21, 2019 3:30:15 PM
1 of the recent tweets even showed brand new mattress lines already completed and ready to rollout on a national basis! And the same tweet even referred to branding support coming with the national rollout.
So it's not like VYST's been sitting on their hands across any aspect of the fresh launch & commercialization endeavors coming, and I can't wait to discover what they mean by national rollout, because that deal alone could be with some significant mainstream retailers in the furnishings sector.
And that's just 1 small example of brand new product lines en route...let alone the dozens of other proprietary competitive advantage products they're prep'n to officially launch that have all already gone through extensive final stage R&D testing/talks with several big names, some we know about and some we don't!
Plus the Q1 results provided a strong statement about multiple "major" manufacturing partners throughout the home furnishings sector coming too!
So VYST's definitely gonna catch the OTC market sleeping when CEO Rotman hits the ground running in the post FEC and Rotmans acquisition era upon us and I fully expect VYST to blow us away with all the fresh valuation driving catalysts they have coming as they finally embark on the up listing journey most of us initially thought was going to start sometime in the back half of February.
All's well that ends well and just imagine how much more they have coming now that it's 3 months later right! Their Q1 results were certainly chockful of fresh clues of just how significant and explosive their pending commercialization is going to be cheers>>>$$$$$$$$$$$$$$$$$$$$
Recent VYST News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 08:06:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 11:01:23 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 10:21:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 07:36:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/26/2023 06:46:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/26/2023 06:41:50 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/10/2023 09:14:55 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM